Similarly, the combination of TREM2 and its ligand not only promotes tumorigenesis, progression, and the high expression of CD163 in tumor-associated macrophages but also amplifies the inflammatory response in the local tumor microenvironment [17]. Here, CD163 is linked to neoplasm.